Authors noted that, among genes identified, several had already been implicated as potential drivers of CML and CML progression including: Asxl1, Myb, Stat5b, and Pten (104). This evidence concerns the gene ASXL1 and chronic myelogenous leukemia, BCR-ABL1 positive.